News Sentiment

SIGHT sentiment intelligence

GenSight Biologics S.A. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 3 relevant articles
Exchange PAR France
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.08 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Balance sheet

54/100 classification confidence.

Company focus 3

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-1.0% over one week, +3.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates

Market Reaction

Balanced read

49/100 confidence

News tone and price action are not far from neutral.

Primary event Balance sheet 54/100 classification
One-week reaction -1.0% Price digesting
Trend fit Trend inactive 3.3% over four weeks
Fair value -70.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 3
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 3
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
marketscreener.com 1
Business Wire 1
BioSpace 1

Event Lens

What the news is about

Classified themes
Balance sheet 1
Earnings 1
Market update 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-3 of 3